Clotiazepam
- Generic Name
- Clotiazepam
- Drug Type
- Small Molecule
- Chemical Formula
- C16H15ClN2OS
- CAS Number
- 33671-46-4
- Unique Ingredient Identifier
- ZCN055599V
- Background
Clotiazepam is a thienodiazepine, not approved for sale in the U.S. or Canada, but has been approved in the U.K. It is a schedule IV drug in Canada.
- Indication
For the treatment of anxiety disorders.
- Associated Conditions
- Anxiety, Insomnia
Bioavailability of Clotiazepam 5 mg With Regards to Reference Product
Phase 1
Completed
- Conditions
- Bioequivalence
- Interventions
- First Posted Date
- 2020-06-19
- Last Posted Date
- 2020-06-19
- Lead Sponsor
- Laboratorios Andromaco S.A.
- Target Recruit Count
- 26
- Registration Number
- NCT04440423
- Locations
- 🇨🇱
Innolab, Santiago, Chile
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath